This cross-sectional study assesses homologous recombination repair mutation genetic testing and associated characteristics among men with metastatic castration-resistant prostate cancer (mCRPC).
JAMA oncology. 2024 May 02 [Epub ahead of print]
Pedro C Barata, Jonathan Assayag, Benjamin Li, Gordon Siu, Alexander Niyazov
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Pfizer Inc, Kirkland, Quebec, Canada., Pfizer Inc, New York, New York.